Mona Shahriari, MD, discusses how RAD 2025 can equip providers with tools to improve atopic dermatitis outcomes.
Mona Shahriari, MD, FAAD
Advertisement
Mona Shahriari, MD, FAAD, assistant clinical professor, Dermatology, Yale University School of Medicine.
Articles by Mona Shahriari, MD, FAAD
Advertisement
Latest Updated Articles
Mona Shahriari, MD previews Revolutionizing Atopic Dermatitis 2025Published: May 2nd 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Safety, tolerability of tenapanor in pediatric IBS-C patients, with Thomas Wallach, MD
2
Julie Khlevner, MD, AGAF, explains the impact of the FDA approval of linaclotide for pediatric IBS-C
3
Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children
4
Odevixibat demonstrates sustained pruritus and bile acid improvements in FIC1 deficiency
5
